|
Volumn 33, Issue 4, 2001, Pages 253-257
|
A case for a neonatal, low-dose BCG vaccination trial
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
IMMUNOGLOBULIN G1;
IMMUNOGLOBULIN G2;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBODY DETECTION;
ARTICLE;
BCG VACCINATION;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
GENETIC HETEROGENEITY;
HUMAN;
IMMUNE RESPONSE;
MEMORY CELL;
MOUSE;
MYCOBACTERIUM TUBERCULOSIS;
NEWBORN;
NEWBORN CARE;
NONHUMAN;
TH1 CELL;
TH2 CELL;
TUBERCULOSIS;
ANIMALS;
ANTIBODY FORMATION;
BCG VACCINE;
CLINICAL TRIALS;
DISEASE MODELS, ANIMAL;
GENETICS, POPULATION;
HUMANS;
IMMUNITY, CELLULAR;
IMMUNOCOMPROMISED HOST;
IMMUNOLOGIC MEMORY;
INFANT, NEWBORN;
MYCOBACTERIUM TUBERCULOSIS;
TUBERCULOSIS;
VACCINATION;
|
EID: 0035062853
PISSN: 00365548
EISSN: None
Source Type: Journal
DOI: 10.1080/003655401300077207 Document Type: Article |
Times cited : (7)
|
References (29)
|